Sanara MedTech (SMTI) Competitors $26.38 +0.10 (+0.38%) Closing price 07/22/2025 04:00 PM EasternExtended Trading$26.40 +0.03 (+0.09%) As of 07/22/2025 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMTI vs. MDXG, INMD, SSII, KMTS, IRMD, SIBN, SMLR, EMBC, CBLL, and BVSShould you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include MiMedx Group (MDXG), InMode (INMD), SS Innovations International (SSII), Kestra Medical Technologies (KMTS), iRadimed (IRMD), SiBone (SIBN), Semler Scientific (SMLR), Embecta (EMBC), CeriBell (CBLL), and Bioventus (BVS). These companies are all part of the "medical equipment" industry. Sanara MedTech vs. Its Competitors MiMedx Group InMode SS Innovations International Kestra Medical Technologies iRadimed SiBone Semler Scientific Embecta CeriBell Bioventus MiMedx Group (NASDAQ:MDXG) and Sanara MedTech (NASDAQ:SMTI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, media sentiment and dividends. Do analysts recommend MDXG or SMTI? MiMedx Group presently has a consensus price target of $11.50, indicating a potential upside of 70.12%. Sanara MedTech has a consensus price target of $49.50, indicating a potential upside of 87.64%. Given Sanara MedTech's higher possible upside, analysts plainly believe Sanara MedTech is more favorable than MiMedx Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MiMedx Group 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is MDXG or SMTI more profitable? MiMedx Group has a net margin of 11.40% compared to Sanara MedTech's net margin of -12.48%. MiMedx Group's return on equity of 22.70% beat Sanara MedTech's return on equity.Company Net Margins Return on Equity Return on Assets MiMedx Group11.40% 22.70% 16.77% Sanara MedTech -12.48%-29.22%-13.20% Which has higher valuation & earnings, MDXG or SMTI? MiMedx Group has higher revenue and earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMiMedx Group$352.38M2.83$42.42M$0.2725.04Sanara MedTech$86.67M2.71-$9.66M-$1.34-19.69 Which has more risk & volatility, MDXG or SMTI? MiMedx Group has a beta of 1.76, meaning that its stock price is 76% more volatile than the S&P 500. Comparatively, Sanara MedTech has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500. Do institutionals and insiders have more ownership in MDXG or SMTI? 79.2% of MiMedx Group shares are owned by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are owned by institutional investors. 1.7% of MiMedx Group shares are owned by insiders. Comparatively, 42.6% of Sanara MedTech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer MDXG or SMTI? In the previous week, MiMedx Group had 4 more articles in the media than Sanara MedTech. MarketBeat recorded 5 mentions for MiMedx Group and 1 mentions for Sanara MedTech. MiMedx Group's average media sentiment score of 0.51 beat Sanara MedTech's score of 0.00 indicating that MiMedx Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiMedx Group 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Sanara MedTech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryMiMedx Group beats Sanara MedTech on 12 of the 14 factors compared between the two stocks. Get Sanara MedTech News Delivered to You Automatically Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMTI vs. The Competition Export to ExcelMetricSanara MedTechMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$233.57M$10.27B$5.49B$9.45BDividend YieldN/A2.06%4.01%4.03%P/E Ratio-19.6917.4428.4719.90Price / Sales2.7128.66410.1985.18Price / CashN/A22.4235.9658.29Price / Book5.933.688.365.67Net Income-$9.66M$234.77M$3.24B$258.18M7 Day Performance-5.41%4.47%3.13%2.81%1 Month Performance-5.18%9.19%10.98%13.53%1 Year Performance-16.78%-16.04%34.54%17.68% Sanara MedTech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMTISanara MedTech1.6238 of 5 stars$26.38+0.4%$49.50+87.6%-15.7%$233.57M$86.67M-19.6960MDXGMiMedx Group3.7061 of 5 stars$6.80+2.1%$12.50+83.8%-8.6%$1.00B$348.88M25.19870Upcoming EarningsINMDInMode4.0565 of 5 stars$14.74+0.2%$18.54+25.8%-18.8%$931.70M$392.41M6.33480Upcoming EarningsSSIISS Innovations InternationalN/A$4.75-4.8%N/AN/A$919.60M$20.65M0.004News CoverageKMTSKestra Medical TechnologiesN/A$15.43+3.5%$27.50+78.2%N/A$792.32M$52.64M0.00300IRMDiRadimed4.5336 of 5 stars$58.07+0.9%$72.00+24.0%+22.2%$738.65M$73.24M37.46110Positive NewsUpcoming EarningsSIBNSiBone2.9693 of 5 stars$17.32+0.7%$22.50+29.9%+2.1%$738.18M$167.18M-27.06350SMLRSemler Scientific2.6966 of 5 stars$45.23-0.7%$89.00+96.8%+17.3%$619.20M$56.29M-17.33120EMBCEmbecta4.5835 of 5 stars$10.37-1.0%$19.33+86.4%-29.6%$606.05M$1.08B11.522,100CBLLCeriBell2.7728 of 5 stars$16.38+1.5%$32.14+96.2%N/A$591.97M$65.44M0.00N/ABVSBioventus3.0598 of 5 stars$6.81-2.3%$13.75+101.9%-12.5%$559.40M$567.70M-11.161,200 Related Companies and Tools Related Companies MiMedx Group Competitors InMode Competitors SS Innovations International Competitors Kestra Medical Technologies Competitors iRadimed Competitors SiBone Competitors Semler Scientific Competitors Embecta Competitors CeriBell Competitors Bioventus Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMTI) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanara MedTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMTI Stock Alerts